William Blair & Company’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.33M Sell
548,779
-5,455
-1% -$36.2K 0.01% 624
2026
Q1
$2.87M Buy
554,234
+17,081
+3% +$107K 0.01% 637
2025
Q4
$3.93M Buy
537,153
+60,703
+13% +$588K 0.01% 581
2025
Q3
$4.75M Buy
476,450
+111,881
+31% +$1.24M 0.01% 528
2025
Q2
$3.3M Buy
364,569
+11,660
+3% +$76K 0.01% 605
2025
Q1
$2.27M Buy
352,909
+54,260
+18% +$483K 0.01% 683
2024
Q4
$2.84M Sell
298,649
-9,486
-3% -$83.3K 0.01% 635
2024
Q3
$2.52M Buy
308,135
+282,629
+1,108% +$2.94M 0.01% 647
2024
Q2
$345K Sell
25,506
-12,732
-33% -$106K ﹤0.01% 1220
2024
Q1
$268K Buy
+38,238
New +$332K ﹤0.01% 1292

Other funds holding ENVX

William Blair & Company's ENVX Position: Q2 2026 in Review

William Blair & Company reduced its Enovix (ENVX) stake by 0.98% in Q2 2026, selling an estimated $36.2K and leaving 548,779 shares worth $3.33M. The position accounts for 0.01% of the portfolio, ranked #624.

William Blair & Company first reported a position in ENVX in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.75M in Q3 2025. 298 funds tracked by Wall St. Rank hold ENVX as of Q2 2026.

  • William Blair & Company held 548,779 shares of Enovix worth $3.33M as of Q2 2026.
  • William Blair & Company sold 5,455 Enovix shares in Q2 2026, an estimated $36.2K.
  • Enovix made up 0.01% of William Blair & Company's portfolio in Q2 2026, its #624 holding.
  • William Blair & Company first reported a position in Enovix in Q1 2024 and has held it in 10 quarters since.
  • William Blair & Company's Enovix position peaked at $4.75M in Q3 2025.
  • 298 funds tracked by Wall St. Rank held Enovix as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.